
McKesson Corporation
MCKNYSEHealthcareMedical - Distribution
Latest quote
$859.69
+$20.15 · +2.40%
MCK company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Buy
Favorable setup — positive multi-factor alignment
Valuation
75
Undervalued
Momentum
47
Neutral
Sentiment
63
Bullish
Risk resilience
78
Moderate Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteMcKesson Corporation is a prominent global provider of healthcare services, operating extensively in both the United States and international markets. Its diverse operations are strategically organized into four key business segments. The U.S. Pharmaceutical division plays a crucial role in the distribution of a comprehensive array of pharmaceutical products, encompassing branded, generic, specialty, biosimilar, and over-the-counter medications, alongside other health-related merchandise. This segment also delivers specialized support to community-based oncology and other specialty medical practices through practice management tools, technology solutions, clinical guidance, and broader business services. Furthermore, it assists pharmacies with consulting, outsourcing, and technology services, while also furnishing financial, operational, and clinical software solutions. Internationally, the company's dedicated segment provides distribution and support services to wholesale, institutional, and retail clients across 13 European nations and Canada. The Medical-Surgical Solutions unit is focused on supplying healthcare providers with essential medical-surgical products, sophisticated logistics management, and a variety of associated services. Finally, the Prescription Technology Solutions (RxTS) segment is designed to address complex medication challenges for patients. It collaborates with biopharmaceutical companies and life sciences partners to improve patient journeys, leveraging innovative solutions for medication access and adherence by connecting pharmacies, healthcare providers, payers, and biopharma entities. This segment further offers third-party logistics and wholesale distribution assistance. Founded in 1833, McKesson Corporation maintains its corporate headquarters in Irving, Texas.
- Industry
- Medical - Distribution
- Sector
- Healthcare
- Headquarters
- US
- CEO
- Brian S. Tyler
- Listed since
- Nov 10, 1994
- Employees
- 42,300
Market position
- Volume
- 835.85K
- 0.75× average
- Average volume
- 1.11M
- Average daily volume
- Market cap
- 100.56B USD
- Beta
- 0.31
- Market reference 1
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 111.6B USD
- P/E (TTM)
- 22.89×
- P/B (TTM)
- -24.05×
- P/S (TTM)
- 0.24×
- EV / EBITDA
- 15.55×
- Earnings yield
- 4.45%
- Free cash flow yield
- 5.06%
- Dividend yield
- 0.38%
Profitability & efficiency
- Gross margin
- 3.64%
- Operating margin
- 1.62%
- Net margin
- 1.12%
- Return on equity
- -219.24%
- Return on assets
- 5.78%
- Return on invested capital
- 31.48%
Financial health
- Debt / equity
- -2.76×
- Current ratio
- 0.85×
- Altman Z-score
- 5.81
- Piotroski F-score
- 7 of 9
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (USD) | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 403.43B USD | 359.05B USD | 308.95B USD | 276.71B USD | 263.97B USD |
| Cost of goods sold | 388.88B USD | 346.57B USD | 296.75B USD | 264.84B USD | 251.32B USD |
| Gross profit | 14.55B USD | 12.49B USD | 12.2B USD | 11.87B USD | 12.65B USD |
| Research and development | 103M USD | 91M USD | 77M USD | 89M USD | 70M USD |
| Selling, general, and administrative | −8.1B USD | 8.02B USD | 8.2B USD | 7.33B USD | 9.86B USD |
| Operating expenses | 8.1B USD | 8.11B USD | 8.28B USD | 7.42B USD | 9.93B USD |
| Interest income | 179M USD | 173M USD | 118M USD | 107M USD | 10M USD |
| Interest expense | 247M USD | 256M USD | 243M USD | 248M USD | 178M USD |
| Depreciation and amortization | 729M USD | 636M USD | 635M USD | 857M USD | 1B USD |
| Operating income | 6.45B USD | 4.37B USD | 3.93B USD | 4.45B USD | 2.72B USD |
| Net income | 4.76B USD | 3.3B USD | 3B USD | 3.56B USD | 1.11B USD |
Company facts updated Aug 24, 2026.
Earnings
- EPS beat rate
- 82%
- 9 beats, 2 misses, 0 met estimates
- Average EPS surprise
- +3.03%
- 11 comparable reports
- Latest EPS result
- 9.93
- Estimate 9.56 · Beat by 3.87%
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
Analyst ratings
Third-party consensus; not a GoAI recommendation.
Recent analyst actions
Corporate actions
Corporate action history
| Action | Effective date | Details | Record date | Payment date |
|---|---|---|---|---|
Stock split | Jan 5, 1998 | 2:1 | — | — |
Effective Jan 5, 1998
2:1
MCK peers
Continue in GoAI
Research MCKresearch.disclaimer





